Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor